Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
This week's topics include:
- House Vote on QALY Legislation
- Legislators Continue to Seek Feedback on 304B Drug Pricing Discussion Draft
- CBO Releases Budget and Economic Outlook, Omits Expected Drug Spending Projections
- This Week: House E&C Committee Subcommittee on Health Legislative Hearing on 19 Bills
- Last Week: Committee Hearings on Drug Shortages; Drug Pricing; AI
- Last Week: House Oversight Committee Advances PBM Legislation
- Congressional Retirements
- CMS Adjusts 2024 Hospital Outpatient Prospective Payment Rates
- CMS 2024 Health Equity Award: Call for Nominations
- HRSA Issues Organ Transplantation RFPs
- CMS Updates Ground Ambulance Data Collection System User Guide; Announces Webinar
- CMS Releases 2021 Medicare Current Beneficiary Survey (MCBS) Chartbook
- MACPAC Policy Brief Released
- Three Medicaid Rules Pending at OMB, Race to Finish Before CRA Begins
- CMS Posts Transcripts from 10 Patient-Focused Listening Sessions for the Medicare Drug Price Negotiation Program
- SAMHSA and ONC Announce the Behavioral Health Information Technology (IT) Initiative
- SAMHSA and OCR Release 42 CFR Part 2 Final Rule
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.